-
公开(公告)号:US20070199856A1
公开(公告)日:2007-08-30
申请号:US11521594
申请日:2006-09-14
申请人: Michael Pesachovich , Sarah Isaacs , Claude Singer , Eduard Schwartz , Edit Berger , Ruth Tenengauzer , Joseph Schwarz , Julia Hrakovsky , Tania Lessen , Lev Khondo , Mathi Mathivanan
发明人: Michael Pesachovich , Sarah Isaacs , Claude Singer , Eduard Schwartz , Edit Berger , Ruth Tenengauzer , Joseph Schwarz , Julia Hrakovsky , Tania Lessen , Lev Khondo , Mathi Mathivanan
IPC分类号: B65D85/84
CPC分类号: A61K9/2009 , A61K9/2013 , A61K9/2027 , A61K9/2054
摘要: A method of packaging of azithromycin which provides improved stability of azithromycin upon storage. Additionally, compositions and methods of stabilizing azithromycin compositions are described. Stabilized azithromycin compositions comprise an intimate admixture of azithromycin and a stabilizing-effective amount of an antioxidant to improve the resistance of the azithromycin to degradation. Coprecipitation or co-milling of azithromycin and an antioxidant are particularly preferred means of achieving an intimate admixture. Pharmaceutical formulations comprising a stabilized azithromycin composition and methods of making such formulations are also described.
摘要翻译: 包装阿奇霉素的方法,其提供阿奇霉素在储存时的改善的稳定性。 另外,描述了稳定阿奇霉素组合物的组合物和方法。 稳定的阿奇霉素组合物包含阿奇霉素和稳定有效量的抗氧化剂的紧密混合物,以改善阿奇霉素降解的抗性。 阿奇霉素和抗氧化剂的共沉淀或共研磨是特别优选的实现紧密混合的方法。 还描述了包含稳定的阿奇霉素组合物的药物制剂和制备这些制剂的方法。
-
公开(公告)号:US20080149521A9
公开(公告)日:2008-06-26
申请号:US11521594
申请日:2006-09-13
申请人: Michael Pesachovich , Sarah Isaacs , Claude Singer , Eduard Schwartz , Edit Berger , Ruth Tenengauzer , Joseph Schwarz , Julia Hrakovsky , Tania Lessen , Lev Khondo , Mathi Mathivanan
发明人: Michael Pesachovich , Sarah Isaacs , Claude Singer , Eduard Schwartz , Edit Berger , Ruth Tenengauzer , Joseph Schwarz , Julia Hrakovsky , Tania Lessen , Lev Khondo , Mathi Mathivanan
IPC分类号: B65D85/84
CPC分类号: A61K9/2009 , A61K9/2013 , A61K9/2027 , A61K9/2054
摘要: A method of packaging of azithromycin which provides improved stability of azithromycin upon storage. Additionally, compositions and methods of stabilizing azithromycin compositions are described. Stabilized azithromycin compositions comprise an intimate admixture of azithromycin and a stabilizing-effective amount of an antioxidant to improve the resistance of the azithromycin to degradation. Coprecipitation or co-milling of azithromycin and an antioxidant are particularly preferred means of achieving an intimate admixture. Pharmaceutical formulations comprising a stabilized azithromycin composition and methods of making such formulations are also described.
摘要翻译: 包装阿奇霉素的方法,其提供阿奇霉素在储存时的改善的稳定性。 另外,描述了稳定阿奇霉素组合物的组合物和方法。 稳定的阿奇霉素组合物包含阿奇霉素和稳定有效量的抗氧化剂的紧密混合物,以改善阿奇霉素降解的抗性。 阿奇霉素和抗氧化剂的共沉淀或共研磨是特别优选的实现紧密混合的方法。 还描述了包含稳定的阿奇霉素组合物的药物制剂和制备这些制剂的方法。
-
公开(公告)号:US06764997B2
公开(公告)日:2004-07-20
申请号:US10274097
申请日:2002-10-18
申请人: Ruth Tenengauzer , Joseph Schwarz , Julia Hrakovsky , Tania Lessen , Lev Khondo , Mathi Mathivanan , Claude Singer , Michael Pesachovich
发明人: Ruth Tenengauzer , Joseph Schwarz , Julia Hrakovsky , Tania Lessen , Lev Khondo , Mathi Mathivanan , Claude Singer , Michael Pesachovich
IPC分类号: A61K3170
CPC分类号: A61K9/1617 , A61K9/0095 , A61K9/145 , A61K9/2077 , A61K31/7052
摘要: Compositions and methods of stabilizing azithromycin compositions are described. Stabilized azithromycin compositions comprise an intimate admixture of azithromycin and a stabilizing-effective amount of an antioxidant to improve the resistance of the azithromycin to degradation. Coprecipitation or co-milling of azithromycin and an antioxidant are particularly preferred means of achieving an intimate admixture. Pharmaceutical formulations comprising a stabilized azithromycin composition and methods of making such formulations are also described.
摘要翻译: 描述了稳定阿奇霉素组合物的组合物和方法。 稳定的阿奇霉素组合物包含阿奇霉素和稳定有效量的抗氧化剂的紧密混合物,以改善阿奇霉素降解的抗性。 阿奇霉素和抗氧化剂的共沉淀或共研磨是特别优选的实现紧密混合的方法。 还描述了包含稳定的阿奇霉素组合物的药物制剂和制备这些制剂的方法。
-
公开(公告)号:US20050106239A1
公开(公告)日:2005-05-19
申请号:US10936075
申请日:2004-09-07
申请人: Ruth Tenengauzer , Joseph Schwarz , Julia Hrakovsky , Tania Lessen , Lev Khondo , Mathi Mathivanan , Claude Singer , Michael Pesachovich
发明人: Ruth Tenengauzer , Joseph Schwarz , Julia Hrakovsky , Tania Lessen , Lev Khondo , Mathi Mathivanan , Claude Singer , Michael Pesachovich
IPC分类号: A61K9/00 , A61K9/14 , A61K9/16 , A61K9/20 , A61K31/353 , A61K31/375 , A61K31/70 , A61K31/7048 , A61K31/7052 , A61K47/10
CPC分类号: A61K9/1617 , A61K9/0095 , A61K9/145 , A61K9/2077 , A61K31/7052
摘要: Compositions and methods of stabilizing azithromycin compositions are described. Stabilized azithromycin compositions comprise an intimate admixture of azithromycin and a stabilizing-effective amount of an antioxidant to improve the resistance of the azithromycin to degradation. Coprecipitation or co-milling of azithromycin and an antioxidant are particularly preferred means of achieving an intimate admixture. Pharmaceutical formulations comprising a stabilized azithromycin composition and methods of making such formulations are also described.
摘要翻译: 描述了稳定阿奇霉素组合物的组合物和方法。 稳定的阿奇霉素组合物包含阿奇霉素和稳定有效量的抗氧化剂的紧密混合物,以改善阿奇霉素降解的抗性。 阿奇霉素和抗氧化剂的共沉淀或共研磨是特别优选的实现紧密混合的方法。 还描述了包含稳定的阿奇霉素组合物的药物制剂和制备这些制剂的方法。
-
公开(公告)号:US20060122271A1
公开(公告)日:2006-06-08
申请号:US11336552
申请日:2006-01-20
IPC分类号: A61K31/195 , A61K9/20
CPC分类号: A61K31/195 , A61K9/145 , A61K9/2013 , A61K9/2054 , A61K9/2059 , C07C227/40 , C07C227/44 , C07C2601/14 , C07D209/96 , C07C229/28
摘要: A pharmaceutical composition containing substantially pure and stable gabapentin are disclosed wherein gabapentin has a pH of between 6.8 to 7.3.
-
公开(公告)号:US06531509B2
公开(公告)日:2003-03-11
申请号:US09880854
申请日:2001-06-15
IPC分类号: A61K31195
CPC分类号: A61K31/195 , A61K9/2054 , A61K9/2059
摘要: Pharmaceutical compositions containing substantially pure and stable gabapentin are disclosed wherein gabapentin contains an anion of a mineral acid, such as chloride, in amounts greater than 20 ppm.
-
公开(公告)号:US06586576B2
公开(公告)日:2003-07-01
申请号:US09755829
申请日:2001-01-04
IPC分类号: C07H1708
摘要: This invention relates to a method for preparing azithromycin dihydrate from crude azithromycin by the gradual crystallization of azithromycin from acetone by the addition of a minimal amount of water to effect crystal formation is disclosed. This invention also relates to a method of making azithromycin from desmethyl-azithromycin by dissolving desmethyl-azithromycin in acetone, adding activated carbon, adding formaldehyde, adding formic acid; refluxing the desmethyl-azithromycin acetone solution, adding sodium hydroxide to induce precipitation of azithromycin, and isolating azithromycin.
摘要翻译: 本发明涉及从阿奇霉素制备阿奇霉素二水合物的方法,其通过加入最少量的水来实现晶体形成,由阿奇霉素从丙酮中逐渐结晶。 本发明还涉及通过将去甲基 - 阿奇霉素溶解在丙酮中,加入活性炭,加入甲醛,加入甲酸,由去甲基 - 阿奇霉素制备阿奇霉素的方法。 回流脱甲基阿奇霉素丙酮溶液,加入氢氧化钠诱导阿奇霉素沉淀,分离阿奇霉素。
-
公开(公告)号:US06255526B1
公开(公告)日:2001-07-03
申请号:US09331555
申请日:1999-06-22
IPC分类号: C07C6106
CPC分类号: C07C227/42 , C07C229/28 , C07C2601/14
摘要: There is disclosed a method of converting gabapenting hydrochloride substantially free of inorganic salts to gabapenting form II. The method comprises the steps of: (1) obtaining gabapentin hydrochloride that is substantially free of inorganic salts; (2) mixing a solution of the gabapenting hydrochloride with an additional amine in a first solvent so as to obtain a precipitate comprising gabapenting; and then (3) recovering gabapentin form II from the precipitate. The precipitated gabapentin is a novel polymorphic form of gabapentin possessing a crystalline structure characterized by novel sets of peaks in the powder X-ray diffraction pattern and in the FTIR spectra. This newly disclosed polymorph of gabapentin is characterized herein as gabapentin form III. The recovery step may comprise, for example, one of two alternative methods, slurrying the gabapentin form II in methanol, and then filtering the suspension to obtain gabapentin form II, or solubilizing the gabapentin form III in methanol with heating by reflux, and then cooling the solution to obtain gabapentin form II by crystallization.
摘要翻译: 公开了一种将基本上不含无机盐的盐酸氢化盐转化为耙状II的方法。 该方法包括以下步骤:(1)获得基本上不含无机盐的盐酸加巴喷丁; (2)在第一溶剂中将加巴喷丁盐酸盐溶液与另外的胺混合,以获得包含加砂的沉淀物; 然后(3)从沉淀物中回收加巴喷丁II型。 沉淀的加巴喷丁是一种具有特征在于粉末X射线衍射图和FTIR光谱中新颖的峰组的加巴喷丁的新型多晶型物。 这种新公开的加巴喷丁多晶型物在本文中被表征为加巴喷丁形式III。 回收步骤可以包括例如两种替代方法之一,将加巴喷丁II型在甲醇中制浆,然后过滤悬浮液以获得形式II的加巴喷丁,或者通过回流加热将加巴喷丁形式III溶解在甲醇中,然后冷却 通过结晶获得形式II的加巴喷丁的溶液。
-
公开(公告)号:US06600073B1
公开(公告)日:2003-07-29
申请号:US09586842
申请日:2000-06-05
申请人: Eduard Schwartz , Tamar Nidam , Anita Liberman , Marioara Mendelovici , Judith Aronhime , Claude Singer , Evgeni Valdman
发明人: Eduard Schwartz , Tamar Nidam , Anita Liberman , Marioara Mendelovici , Judith Aronhime , Claude Singer , Evgeni Valdman
IPC分类号: C07C21100
CPC分类号: C07C209/84 , A61K31/135 , C07C211/42 , C07C2602/10
摘要: Novel methods for the preparation of sertraline hydrochloride Forms III, V, VI, VII, VII, IX and X are disclosed. According to the present invention, sertraline hydrochloride Form III may be produced by heating sertraline hydrochloride Forms V and VI. Sertraline hydrochloride Forms V and VI may be produced from either sertraline hydrochloride or sertraline base by crystallization. Sertraline hydrochloride Form VII may be produced by suspending sertraline chloride polymorph V in water, followed by filtration. Sertraline hydrochloride Forms VIII and IX may be produced by suspending sertraline base in water followed by acidification and filtration. Sertraline hydrochloride Form X may be produced by suspending sertraline hydrochloride in benzyl alcohol with heating, followed by filtration.
摘要翻译: 公开了制备盐酸舍曲林的新方法,形式III,V,VI,VII,VII,IX和X。 根据本发明,盐酸舍曲林盐酸盐形式III可以通过加热盐酸舍曲林形式V和VI来制备。 盐酸舍曲林形式V和VI可以通过结晶从舍曲林盐酸盐或舍曲林碱产生。 盐酸舍曲林形式VII可以通过将舍曲林氯化物多晶型V悬浮在水中,然后过滤来制备。 盐酸舍曲林形式VIII和IX可以通过将舍曲林碱悬浮在水中然后酸化和过滤来制备。 舍曲林盐酸盐形式X可以通过在加热下将舍曲林盐酸舍曲林悬浮在苄醇中,然后过滤来制备。
-
公开(公告)号:US20080176949A1
公开(公告)日:2008-07-24
申请号:US12077993
申请日:2008-03-21
申请人: Eduard Schwartz , Tamar Nidam , Anita Liberman , Marioara Mendelovici , Judith Aronhime , Claude Singer , Evgeni Valdman
发明人: Eduard Schwartz , Tamar Nidam , Anita Liberman , Marioara Mendelovici , Judith Aronhime , Claude Singer , Evgeni Valdman
IPC分类号: A61K31/135 , A61P43/00 , C07C211/33
CPC分类号: C07C209/84 , A61K31/135 , C07C211/42 , C07C2602/10
摘要: The present invention is directed to forms II, III, V, VI, VII, VIII, IX and X of sertraline hydrochloride and novel methods for their preparation. According to the present invention, sertraline hydrochloride polymorph II may be produced by slurrying sertraline hydrochloride polymorph VI in aprotic organic solvent. Sertraline hydrochloride polymorphic form III may be produced by heating sertraline hydrochloride polymorphs V and VI. Sertraline hydrochloride forms V and VI may be produced from either sertraline hydrochloride or sertraline base by crystallization. Sertraline hydrochloride Form VII may be produced by suspending sertraline chloride polymorph V in water, followed by filtration. Sertraline hydrochloride Forms VIII and IX may be produced by suspending sertraline base in water followed by acidification and filtration. Sertraline hydrochloride Form X may be produced by suspending sertraline hydrochloride in benzyl alcohol with heating, followed by filtration.
摘要翻译: 本发明涉及舍曲林盐酸盐的形式II,III,V,VI,VII,VIII,IX和X及其制备方法。 根据本发明,盐酸舍曲林多晶型II可以通过将盐酸舍曲林多晶型VI制成非质子有机溶剂来制备。 舍曲林盐酸盐多晶型III可以通过加热舍曲林盐酸盐多晶型物V和VI来制备。 舍曲林盐酸盐形成V和VI可以通过结晶从舍曲林盐酸盐或舍曲林碱产生。 盐酸舍曲林形式VII可以通过将舍曲林氯化物多晶型V悬浮在水中,然后过滤来制备。 盐酸舍曲林形式VIII和IX可以通过将舍曲林碱悬浮在水中然后酸化和过滤来制备。 舍曲林盐酸盐形式X可以通过在加热下将舍曲林盐酸舍曲林悬浮在苄醇中,然后过滤来制备。
-
-
-
-
-
-
-
-
-